Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 29 min ago
Peer-reviewedCC BYRSC advances

Salmon bone-derived chondroitin sulfate nanogels for controlled delivery of curcumin: release behavior, structural characteristics and anti-inflammatory efficacy.

  1. 1Institute of Chemistry, Vietnam Academy of Science and Technology 18 Hoang Quoc Viet, Nghia Do Hanoi 100000 Vietnam [email protected].
  2. 2School of Chemistry and Life Science, Hanoi University of Science and Technology 01 Dai Co Viet, Bach Mai Hanoi 100000 Vietnam.

Abstract

Marine-derived polysaccharides have emerged as sustainable biomaterials for advanced drug delivery; however, the relationship between their molecular organization and drug release behavior remains insufficiently understood. In this study, chondroitin sulfate (CS) extracted from salmon bone was utilized to fabricate Ca²⁺-crosslinked nanogels for the controlled delivery of curcumin (Cur). The optimized nanogels exhibited a hydrodynamic diameter of 217.3 ± 15.6 nm, a polydispersity index of 0.25 ± 0.02, and a negative zeta potential of -26.9 ± 0.14 mV, indicating good colloidal stability. Comprehensive structural characterization via FT-IR and XRD indicated that the nanogel framework is stabilized by Ca²⁺-mediated ionic crosslinking and multi-point hydrogen bonding. Notably, XRD analysis revealed that while encapsulated curcumin primarily adopts an amorphous molecular dispersion, the emergence of a specific reflection at 2θ ≈ 14° suggests that a minor fraction adopts a locally ordered state stabilized within the nanogel microenvironment. The nanogels demonstrated a sustained biphasic release profile governed by anomalous (non-Fickian) diffusion (n = 0.711). Furthermore, in LPS-stimulated RAW 264.7 macrophages, the CS-Cur nanogels showed significantly enhanced anti-inflammatory efficacy and high biocompatibility compared to free curcumin. These findings highlight salmon bone-derived CS as a sustainable, high-performance matrix for hydrophobic drug delivery, providing new insights into the role of cargo-induced structural organization in regulating therapeutic release and biological performance.

Related

  1. Anti-inflammatory potential of Astragalus polysaccharides: structural characteristics, mechanisms and clinical translation
    Xue Zhao, Haixin Ding, Bo Wang +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  2. Effects of Chondroitin Sulfate on Joint Symptoms and Physical Function in Adults with Mild Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial
    Hyang-Im Baek, Soo Jung Park
    NutrientsPeer-reviewedCC BY 4.0Full textNutritionCrossrefEurope PMC
  3. Inflammatory Burden, Structural Exposure, and Racial Disparities in Incident Heart Failure: Evidence from the Multi-Ethnic Study of Atherosclerosis
    F. E. Rivera-Mariani, T. Campbell, E. Solomon
    medRxivPreprintAll rights reservedFull textCardiovascular medicinemedRxiv
  4. Participant Characteristics Associated With Loneliness Reduction During a Digital Social Robot Intervention Among Older Adults Living Alone in Japan: Secondary Analysis of a Randomized Controlled Trial
    Hiroshi Murayama, Mai Takase
    Journal of Medical Internet ResearchPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  5. Clinical Characteristics and Outcomes of Patients Undergoing Pericardiocentesis for Pericardial Effusion: A Single-Center Experience with Exploratory Inflammatory Biomarker Analysis
    Zeynep Yapan Emren, Gamze Erkılınç
    Journal of clinical medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMCCrossref
BibTeX
@article{ngo2026salmon,
  title = {{Salmon bone-derived chondroitin sulfate nanogels for controlled delivery of curcumin: release behavior, structural characteristics and anti-inflammatory efficacy.}},
  author = {Quang Van Ngo and Nguyen Chi Nguyen and Hong Thi Pham and Cuong Duc Ho and Thu Thi Minh Quach and Thuy Thi Thu Thanh},
  journal = {RSC advances},
  year = {2026},
  month = oct,
  doi = {10.1039/d6ra06378k},
  url = {https://europepmc.org/article/MED/42835591},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Salmon bone-derived chondroitin sulfate nanogels for controlled delivery of curcumin: release behavior, structural characteristics and anti-inflammatory efficacy.
AU  - Quang Van Ngo
AU  - Nguyen Chi Nguyen
AU  - Hong Thi Pham
AU  - Cuong Duc Ho
AU  - Thu Thi Minh Quach
AU  - Thuy Thi Thu Thanh
PY  - 2026
DA  - 2026/10/05
JO  - RSC advances
DO  - 10.1039/d6ra06378k
UR  - https://europepmc.org/article/MED/42835591
AB  - Marine-derived polysaccharides have emerged as sustainable biomaterials for advanced drug delivery; however, the relationship between their molecular organization and drug release behavior remains insufficiently understood. In this study, chondroitin sulfate (CS) extracted from salmon bone was utilized to fabricate Ca²⁺-crosslinked nanogels for the controlled delivery of curcumin (Cur). The optimized nanogels exhibited a hydrodynamic diameter of 217.3 ± 15.6 nm, a polydispersity index of 0.25 ± 0.02, and a negative zeta potential of -26.9 ± 0.14 mV, indicating good colloidal stability. Comprehensive structural characterization via FT-IR and XRD indicated that the nanogel framework is stabilized by Ca²⁺-mediated ionic crosslinking and multi-point hydrogen bonding. Notably, XRD analysis revealed that while encapsulated curcumin primarily adopts an amorphous molecular dispersion, the emergence of a specific reflection at 2θ ≈ 14° suggests that a minor fraction adopts a locally ordered state stabilized within the nanogel microenvironment. The nanogels demonstrated a sustained biphasic release profile governed by anomalous (non-Fickian) diffusion (n = 0.711). Furthermore, in LPS-stimulated RAW 264.7 macrophages, the CS-Cur nanogels showed significantly enhanced anti-inflammatory efficacy and high biocompatibility compared to free curcumin. These findings highlight salmon bone-derived CS as a sustainable, high-performance matrix for hydrophobic drug delivery, providing new insights into the role of cargo-induced structural organization in regulating therapeutic release and biological performance.
SN  - 2046-2069
ER  -